Ticker > Company >

Krsnaa Diagnostics share price

Krsnaa Diagnostics Ltd.

NSE: KRSNAA BSE: 543328 SECTOR: Hospital & Healthcare Services  124k   224   55

970.70
0 0
BSE: 22 Nov 04:00 PM

Price Summary

Today's High

₹ 980

Today's Low

₹ 933

52 Week High

₹ 980

52 Week Low

₹ 527.55

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

3134.37 Cr.

Enterprise Value

3241.13 Cr.

No. of Shares

3.23 Cr.

P/E

43.44

P/B

3.69

Face Value

₹ 5

Div. Yield

0.27 %

Book Value (TTM)

₹  262.88

CASH

53.03 Cr.

DEBT

159.79 Cr.

Promoter Holding

27.17 %

EPS (TTM)

₹  22.34

Sales Growth

27.14%

ROE

7.54 %

ROCE

10.1%

Profit Growth

-7.79 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year27.14%
3 Year14.17%
5 Year23.04%

Profit Growth

1 Year-7.79%
3 Year-31.84%
5 Year24.65%

ROE%

1 Year7.54%
3 Year12.49%
5 Year7.49%

ROCE %

1 Year10.1%
3 Year13.4%
5 Year-11.24%

Debt/Equity

0.1966

Price to Cash Flow

128.49

Interest Cover Ratio

5.3694

CFO/PAT (5 Yr. Avg.)

1.44892982931455

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 27.17 0.00
Jun 2024 27.17 0.00
Mar 2024 27.03 0.00
Dec 2023 27.03 0.00
Sep 2023 27.80 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has an efficient Cash Conversion Cycle of -81.1324 days.
  • The company has a good cash flow management; CFO/PAT stands at 1.44892982931455.

 Limitations

  • The company has shown a poor profit growth of -31.8388420688697% for the Past 3 years.
  • The company has shown a poor revenue growth of 14.1711630501172% for the Past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Net Sales 146.85 151.55 159.33 163.16 178.72
Total Expenditure 114.31 113.39 116.06 120.18 126.24
Operating Profit 32.55 38.16 43.27 42.98 52.48
Other Income 4.16 4.08 4.34 7.32 4.6
Interest 3.06 4.14 7.32 5.3 6.39
Depreciation 19.46 21.23 18.12 21.47 22.2
Exceptional Items 0 0 0 0 0
Profit Before Tax 14.18 16.87 22.18 23.53 28.5
Tax 2.88 3.28 3.76 5.35 6.53
Profit After Tax 11.31 13.59 18.42 18.18 21.97
Adjusted EPS (Rs) 3.6 4.21 5.7 5.63 6.8

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 258.43 396.46 454.89 464.08 590.02
Total Expenditure 372.64 302.65 320.34 339.84 443.86
Operating Profit -114.21 93.81 134.55 124.25 146.16
Other Income 12.95 265.02 14.93 19.41 16.8
Interest 24.66 25.94 18.49 7.68 16.47
Depreciation 32.41 37.44 41.39 53.78 74.55
Exceptional Items 0 0 0 0 0
Profit Before Tax -158.33 295.45 89.6 82.19 71.95
Tax -46.38 110.52 18.9 18.68 13.38
Net Profit -111.95 184.93 70.7 63.51 58.56
Adjusted EPS (Rs.) -108.42 142.36 22.52 20.23 18.14

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 20.19 248.89 15.7 15.7 16.15
Total Reserves -217.16 -17.02 671.05 726.8 799.1
Borrowings 122.71 167.95 33.07 24.28 41.88
Other N/C liabilities 431.28 20.91 37.59 47.35 38.39
Current liabilities 180.8 188.55 119.64 95.25 276.05
Total Liabilities 537.81 609.28 877.06 909.38 1171.57
Assets
Net Block 275.1 308.51 385.69 470.68 647.16
Capital WIP 9.13 3.72 28.26 25.48 9.85
Intangible WIP 0 0 0 0 0
Investments 0.29 0.29 0.36 0.36 0.36
Loans & Advances 28.16 33.83 17.87 26.37 62.37
Other N/C Assets 11.51 10.04 109.11 162.75 29.43
Current Assets 213.63 252.89 335.77 223.75 422.41
Total Assets 537.81 609.28 877.06 909.38 1171.57
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations -158.33 295.45 89.6 82.19 71.95
Adjustment 225.66 -198.74 49.2 44.79 69.9
Changes in Assets & Liabilities -19.32 29.62 -3.46 -38.37 -98.65
Tax Paid -10.2 -7.67 -6.63 -13.13 -18.8
Operating Cash Flow 37.81 118.66 128.71 75.48 24.39
Investing Cash Flow -76.65 -67.37 -241.1 -108.54 -128.88
Financing Cash Flow 5.78 20.03 176.04 -33.13 84.21
Net Cash Flow -33.06 71.32 63.65 -66.19 -20.27

Corporate Actions

Investors Details

PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
promoters 27.80 27.03 27.03 27.17 27.17
krsna diagnostics (mumbai... 2.22 2.16 2.16 2.30 2.30
rajendra khivraj mutha 25.57 24.87 24.87 24.87 24.87
PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
investors 72.20 72.97 72.97 72.83 72.83
bandhan bse healthcare in... - - - - 1.34
hdfc life insurance compa... 1.98 1.93 1.93 2.06 2.06
icici prudential pharma h... - 3.70 2.73 2.73 2.15
k india opportunities fun... - - - 2.19 2.19
kirankumar prabhakar bhis... 1.47 1.41 1.52 1.57 1.20
phi capital trust - phi c... 15.88 15.44 15.44 15.44 15.44
tata mutual fund - tata s... 6.59 7.40 7.40 7.73 7.73
bandhan small cap fund - - - 1.33 -
aditya birla sun life ins... 2.05 1.69 1.36 - -
cybage software private l... - - 1.00 - -
k india opportunities fun... - - 2.19 - -
kitara piin 1104 3.55 2.95 1.26 - -
acm global fund vcc 2.62 2.00 - - -
icici prudential smallcap... 5.40 - - - -
inevsco india smallcap fu... 1.30 - - - -
medimaze solutions privat... 1.75 - - - -

Ratings & Research Reports

Company Presentations

Company News

Krsnaa Diagnostics informs about analyst meet 6 Nov, 12:52 PM Krsnaa Diagnostics - Quaterly Results 25 Oct, 8:29 PM Krsnaa Diagnostics - Quaterly Results 25 Oct, 8:29 PM Krsnaa Diagnostics to expand Radiology services, Pathology laboratory services in Ranchi 11 Oct, 10:22 AM Krsnaa Diagnostics informs about analyst meet 8 Oct, 4:56 PM Krsnaa Diagnostics enters into strategic partnership with Medikabazaar 1 Oct, 2:40 PM Krsnaa Diagnostics acquires strategic stake in Apulki Healthcare 26 Sep, 4:51 PM Krsnaa Diagnostics submits analyst meet intimation 27 Aug, 12:44 PM Krsnaa Diagnostics informs about newspaper publication 24 Aug, 2:46 PM Krsnaa Diagnostics informs about newspaper publication 8 Aug, 1:14 PM Krsnaa Diagnostics - Quaterly Results 6 Aug, 7:13 PM Krsnaa Diagnostics - Quaterly Results 6 Aug, 7:13 PM Krsnaa Diagnostics gets tender from Bhabha Atomic Research Centre 5 Jul, 10:58 AM Krsnaa Diagnostics informs about closure of trading window 22 Jun, 3:53 PM Krsnaa Diagnostics - Quaterly Results 18 May, 7:35 PM Krsnaa Diagnostics - Quaterly Results 18 May, 7:35 PM Krsnaa Diagnostics inks pact with Government of Maharashtra 2 May, 3:29 PM Krsnaa Diagnostics incorporates wholly owned subsidiary 9 Apr, 3:26 PM Krsnaa Diagnostics informs about newspaper publication 6 Mar, 12:33 PM Krsnaa Diagnostics informs about analyst meet 5 Mar, 5:30 PM Krsnaa Diagnostics informs about notice of postal ballot 5 Mar, 12:31 PM Krsnaa Diagnostics informs about investors meet 23 Feb, 2:43 PM Krsnaa Diagnostics submits analyst meet intimation 23 Feb, 12:32 PM Krsnaa Diagnostics informs about analyst meet 20 Feb, 3:27 PM Krsnaa Diagnostics informs about resignation of managing director 13 Feb, 10:02 AM Krsnaa Diagnostics informs about grant of options under ESOS 13 Feb, 9:56 AM Krsnaa Diagnostics informs about incorporation of WOS 13 Feb, 9:55 AM Krsnaa Diagnostics gets nod to incorporate wholly owned subsidiary 13 Feb, 9:48 AM Krsnaa Diagnostics - Quaterly Results 12 Feb, 10:01 PM Krsnaa Diagnostics - Quaterly Results 12 Feb, 10:01 PM Krsnaa Diagnostics bags contract to provide MRI, CT Scan Services in Maharashtra 30 Jan, 11:28 AM Krsnaa Diagnostics informs about analyst meet 18 Jan, 2:28 PM Krsnaa Diagnostics informs about disclosure 1 Jan, 4:40 PM Krsnaa Diagnostics submits Disclosure 9 Dec, 2:49 PM Krsnaa Diagnostics submits analyst meet intimation 4 Dec, 4:55 PM Krsnaa Diagnostics submits analyst meet intimation 30 Nov, 4:33 PM Krsnaa Diagnostics informs about analyst meet 28 Nov, 3:02 PM Krsnaa Diagnostics informs about allotment of equity shares ESOS 28 Nov, 3:01 PM Krsnaa Diagnostics informs about analyst meet 24 Nov, 4:28 PM Krsnaa Diagnostics informs about monitoring agency report 9 Nov, 4:06 PM Krsnaa Diagnostics - Quaterly Results 3 Nov, 6:28 PM Krsnaa Diagnostics - Quaterly Results 3 Nov, 6:28 PM Krsnaa Diagnostics informs about newspaper publication 4 Sep, 4:42 PM Krsnaa Diagnostics submits AGM notice and annual report 2 Sep, 2:38 PM Krsnaa Diagnostics informs about newspaper publications 28 Aug, 3:27 PM Krsnaa Diagnostics submits analyst meet intimation 19 Aug, 4:28 PM Krsnaa Diagnostics informs about newspaper publication 14 Aug, 4:11 PM Krsnaa Diagnostics - Quaterly Results 12 Aug, 7:43 PM Krsnaa Diagnostics - Quaterly Results 12 Aug, 7:43 PM Krsnaa Diagnostics informs about appointment of CO 24 Jul, 1:48 PM

Krsnaa Diagnostics Stock Price Analysis and Quick Research Report. Is Krsnaa Diagnostics an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Krsnaa Diagnostics and its performance over the period of time. Krsnaa Diagnostics stock price today is Rs 972.25.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Krsnaa Diagnostics cash from the operating activity was Rs 24.394 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Krsnaa Diagnostics has a Debt to Equity ratio of 0.1966 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Krsnaa Diagnostics , the EPS growth was -10.3366 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Krsnaa Diagnostics has OPM of 24.772592069069 % which is a good sign for profitability.
     
  • ROE: Krsnaa Diagnostics have a poor ROE of 7.5433 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Krsnaa Diagnostics is Rs 972.25. One can use valuation calculators of ticker to know if Krsnaa Diagnostics share price is undervalued or overvalued.
Last Updated on:
Brief about Krsnaa Diagnostics

Krsnaa Diagnostics Ltd. Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

Krsnaa Diagnostics Ltd. is a leading diagnostics service provider in India. With a strong presence in both urban and rural areas, the company is committed to providing high-quality diagnostic services to its customers. Krsnaa Diagnostics offers a wide range of diagnostic services including pathology, radiology, imaging, and tele-radiology services.

The company has a well-established network of diagnostic centers and offers its services through a hub-and-spoke model, allowing it to reach a larger customer base. Krsnaa Diagnostics is known for its state-of-the-art infrastructure, advanced technology, and highly skilled professionals.

Krsnaa Diagnostics Ltd. - Share Price

Investors interested in Krsnaa Diagnostics Ltd. can keep track of its share price on our website. We provide real-time updates on the stock's performance, allowing investors to make informed decisions. Our website also offers pre-built screening tools that enable investors to analyze the company's share price over different time periods and compare it to industry peers.

Krsnaa Diagnostics Ltd. - Balance Sheet

The balance sheet of Krsnaa Diagnostics Ltd. provides a snapshot of the company's financial position. Investors can access the company's annual reports on our website, which include detailed information about its assets, liabilities, and shareholders' equity. For a comprehensive analysis, our premium features allow fair value calculation through tools such as DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis.

Krsnaa Diagnostics Ltd. - Annual Report

Krsnaa Diagnostics Ltd. releases its annual reports on our website, which provide a comprehensive overview of the company's performance throughout the year. These reports include valuable information about the company's financial statements, business operations, growth prospects, and future plans. Investors can download these reports to gain insights and make informed investment decisions.

Krsnaa Diagnostics Ltd. - Dividend

Investors interested in dividends can find information about Krsnaa Diagnostics Ltd.'s dividend payments on our website. We provide updates on the company's dividend history, including the amount paid and the dividend yield. Investors can use this information to assess the company's dividend policy and evaluate its potential as an income-generating investment.

Krsnaa Diagnostics Ltd. - Quarterly Result

Tracking Krsnaa Diagnostics Ltd.'s quarterly results is essential for investors. Our website offers quarterly result updates, allowing investors to stay informed about the company's financial performance and analyze trends over time. Our premium features enable investors to conduct in-depth analysis and calculate the fair value of the stock using various tools.

Krsnaa Diagnostics Ltd. - Stock Price

Our website provides real-time updates on Krsnaa Diagnostics Ltd.'s stock price. Investors can track the stock's performance and view price charts to identify patterns or trends. We also offer pre-built screening tools to analyze the stock price and compare it to industry peers, helping investors make informed investment decisions.

Krsnaa Diagnostics Ltd. - Price Chart

Monitoring the price chart of Krsnaa Diagnostics Ltd.'s stock is crucial for investors. Our website offers interactive price charts that provide a visual representation of the stock's performance over different time periods. Investors can use these charts to identify historical price patterns and make predictions about future price movements.

Krsnaa Diagnostics Ltd. - News

Stay updated with the latest news about Krsnaa Diagnostics Ltd. on our website. We provide timely news updates related to the company's business operations, financial performance, strategic partnerships, and other relevant events. Investors can access these news articles to stay informed and make well-informed investment decisions.

Krsnaa Diagnostics Ltd. - Concall Transcripts

Investors interested in gaining insights from Krsnaa Diagnostics Ltd.'s investor conference calls can access the transcripts on our website. These transcripts provide a verbatim record of the discussions and presentations during the conference calls. Investors can refer to these transcripts for detailed information about the company's strategy, financial performance, and future outlook.

Krsnaa Diagnostics Ltd. - Investor Presentations

Krsnaa Diagnostics Ltd. provides investor presentations on our website. These presentations offer valuable insights into the company's business model, growth prospects, and financial performance. Investors can download these presentations to gain a deeper understanding of the company and make informed investment decisions.

Krsnaa Diagnostics Ltd. - Promoters

Krsnaa Diagnostics Ltd. has a dedicated team of promoters who have played a vital role in the company's growth and success. Our website provides information about the promoters, their backgrounds, and their contributions to the company. Knowing about the promoters can help investors gauge the company's leadership and their commitment to long-term growth.

Krsnaa Diagnostics Ltd. - Shareholders

Understanding the company's shareholders is crucial for investors. Our website provides information about Krsnaa Diagnostics Ltd.'s major shareholders, including institutional investors and individual investors. Investors can analyze the shareholding pattern to assess the confidence of other investors in the company and make informed investment decisions.

Remember, you can find additional tools and resources on our website, such as annual reports, concall transcripts, investor presentations, credit ratings, and research reports, to support your stock analysis. We aim to provide comprehensive information and analysis that will be valuable to long-term stock investors.

Read More
X